Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2025 Earnings Call Transcript

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Nation

Wooden tongue disease in cows and how to manage it

The treatment works by killing the virus as it attempts to establish for multiplication in the skin of the hooves and the ...

Explore the ways animals and plants protect human health and what’s at stake when species are endangered.

You’ve heard the slogans: save the whales, protect our pollinators. You may have lamented the decline of polar bears or the ...

Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...